Known molecular drivers of Wilms tumor commonly involve disruptions to key transcription factors (TFs) (e.g., WT1, SIX2) and signaling proteins (e.g., IGF2, WTX, β-catenin) crucial for nephrogenesis5,20. The gene discussed is WT1; the disease is Nephroblastoma.